-
1
-
-
0034614637
-
The hallmarks of cancer
-
10647931,; PMID
-
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
2
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
21376230,; PMID
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
3
-
-
84931576146
-
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
-
PMID: 25132267; http://dx.doi.org/
-
Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene 2014; PMID: 25132267; http://dx.doi.org/10.1038/onc.2014.264
-
(2014)
Oncogene
-
-
Cai, Q.1
Yan, L.2
Xu, Y.3
-
4
-
-
0029870954
-
The war on cancer
-
8637346,; PMID
-
Sporn MB. The war on cancer. Lancet 1996; 347:1377-81; PMID:8637346; http://dx.doi.org/10.1016/S0140-6736(96)91015-6
-
(1996)
Lancet
, vol.347
, pp. 1377-1381
-
-
Sporn, M.B.1
-
5
-
-
84895809519
-
Cancer as a metabolic disease: implications for novel therapeutics
-
24343361,; PMID
-
Seyfried TN, Flores RE, Poff AM, D’Agostino DP. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis 2014; 35:515-27; PMID:24343361; http://dx.doi.org/10.1093/carcin/bgt480
-
(2014)
Carcinogenesis
, vol.35
, pp. 515-527
-
-
Seyfried, T.N.1
Flores, R.E.2
Poff, A.M.3
D’Agostino, D.P.4
-
6
-
-
84858722900
-
Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10
-
22321370,; PMID
-
Hebert-Chatelain E, Jose C, Gutierrez Cortes N, Dupuy JW, Rocher C, Dachary-Prigent J, Letellier T. Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10. Biochimica et biophysica acta 2012; 1817:718-25; PMID:22321370; http://dx.doi.org/10.1016/j.bbabio.2012.01.014
-
(2012)
Biochimica et biophysica acta
, vol.1817
, pp. 718-725
-
-
Hebert-Chatelain, E.1
Jose, C.2
Gutierrez Cortes, N.3
Dupuy, J.W.4
Rocher, C.5
Dachary-Prigent, J.6
Letellier, T.7
-
7
-
-
84879736127
-
Towards a metabolic therapy of cancer?
-
23762991,; PMID
-
Chiu M, Ottaviani L, Bianchi MG, Franchi-Gazzola R, Bussolati O. Towards a metabolic therapy of cancer? Acta bio-medica: Atenei Parmensis 2012; 83:168-76; PMID:23762991
-
(2012)
Acta bio-medica : Atenei Parmensis
, vol.83
, pp. 168-176
-
-
Chiu, M.1
Ottaviani, L.2
Bianchi, M.G.3
Franchi-Gazzola, R.4
Bussolati, O.5
-
8
-
-
79960805560
-
Metabolic approaches to overcoming chemoresistance in ovarian cancer
-
21793839,; PMID
-
Suh DH, Kim MK, No JH, Chung HH, Song YS. Metabolic approaches to overcoming chemoresistance in ovarian cancer. Ann New York Acad Sci 2011; 1229:53-60; PMID:21793839; http://dx.doi.org/10.1111/j.1749-6632.2011.06095.x
-
(2011)
Ann New York Acad Sci
, vol.1229
, pp. 53-60
-
-
Suh, D.H.1
Kim, M.K.2
No, J.H.3
Chung, H.H.4
Song, Y.S.5
|